c) Maligniteter og lymfoproliferative sygdomme Det vides endnu ikke, om Raptiva kan øge risikoen for lymfoproliferative sygdomme eller andre maligniteter hos psoriasis- patienter.
c) Malignancies and lymphoproliferative disorders It is not yet known whether or not Raptiva can increase the risk of lymphoproliferative disorders or other malignancies in psoriasis patients.